Scarica l'app Stockscreener
353.93
1.58%
5.50
Dopo l'orario di chiusura:
351.80
-2.13
-0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$348.43
Aprire:
$350.76
Volume 24 ore:
1.84M
Relative Volume:
0.65
Capitalizzazione di mercato:
$190.79B
Reddito:
$36.74B
Utile/perdita netta:
$7.71B
Rapporto P/E:
24.87
EPS:
14.2333
Flusso di cassa netto:
$8.10B
1 W Prestazione:
+0.70%
1M Prestazione:
-7.91%
6M Prestazione:
+30.51%
1 anno Prestazione:
+15.34%
Intervallo 1D:
$350.76
$358.00
Intervallo di 1 settimana:
$344.95
$358.00
Portata 52W:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, AZN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
353.93 | 187.83B | 36.74B | 7.71B | 8.10B | 14.23 |
LLY
Lilly Eli Co
|
916.31 | 806.39B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
239.93 | 566.67B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
207.18 | 362.83B | 61.16B | 4.19B | 17.82B | 2.3614 |
MRK
Merck Co Inc
|
119.37 | 287.71B | 64.93B | 18.26B | 12.36B | 7.2751 |
AZN
Astrazeneca Plc
|
187.14 | 288.11B | 58.80B | 10.24B | 8.98B | 3.2788 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-10 | Iniziato | Jefferies | Hold |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-01-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere - Amgen
Amgen Named One of the World’s Most Ethical Companies® by Ethisphere - Amgen
Amgen’s Rocatinlimab Trial Completion Signals Next Phase for Atopic Dermatitis Strategy - TipRanks
Wells Fargo raises its price target on Amgen (AMGN) to $390 from $375 - MSN
Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375 - Yahoo Finance Singapore
Pensionfund Sabic Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Assenagon Asset Management S.A. Sells 59,138 Shares of Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation After Recent Share Price Pullback And Mixed Short Term Returns - Yahoo Finance
SG Americas Securities LLC Acquires 113,909 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN - MarketBeat
Avanza Fonder AB Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Lilly, Amgen Seek Fast Win in Suit Over Clinics in Discount Plan - Bloomberg Law News
The Genetic Puzzle of Heart Disease: Inside Amgen’s Commitment to Lp(a) - Amgen
Marshall Financial Group LLC Purchases New Position in Amgen Inc. $AMGN - MarketBeat
180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc stock faces institutional selling pressure amid mixed 13F filings and dividend stability - AD HOC NEWS
Amgen Shares Sold by Sarasin & Partners LLP - National Today
Amgen Inc. stock faces pressure amid pipeline setbacks and market rotation in biotech sector - AD HOC NEWS
Wealth Enhancement Advisory Services LLC Trims Stake in Amgen Inc. $AMGN - MarketBeat
Nordea Investment Management AB Sells 273,268 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Sarasin & Partners LLP - MarketBeat
How Amgen Makes Money - Investopedia
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
Amgen Inc. (AMGN) collaborates on ending anti-OX40 clinical studies - MSN
2 Healthcare Stocks to Buy Before They Get Bought Out - The Motley Fool
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen buys cancer drug developer Dark Blue in $840 million deal - MSN
Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation - simplywall.st
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
A28T12 Latest News and Headlines - TradingView
Amgen Expands Oncology Pipeline With New Phase 1 AMG 436 Study in MSI-H/dMMR Tumors - TipRanks
AMGN Trading Above 50 & 200-Day SMA: How to Play the Stock? - TradingView
Amgen (NASDAQ:AMGN) Given New $390.00 Price Target at Wells Fargo & Company - MarketBeat
Wells Fargo Adjusts Price Target on Amgen to $390 From $375, Maintains Equalweight Rating - marketscreener.com
Swiss Life Asset Management Ltd Buys 6,082 Shares of Amgen Inc. $AMGN - MarketBeat
GAMMA Investing LLC Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Mainstay Capital Management LLC ADV Sells 4,865 Shares of Amgen Inc. $AMGN - MarketBeat
Stillwater Wealth Management Group Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
Investment Research Partners LLC Invests $1.06 Million in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. stock faces pressure amid 2026 guidance scrutiny and sector headwinds - AD HOC NEWS
93,962 Shares in Amgen Inc. $AMGN Acquired by CIBC Bancorp USA Inc. - MarketBeat
Amgen Inc. $AMGN Shares Purchased by AIA Group Ltd - MarketBeat
[Form 4] AMGEN INC Insider Trading Activity - Stock Titan
Amgen (NASDAQ: AMGN) EVP Santos has shares withheld for taxes - Stock Titan
Amgen (NASDAQ: AMGN) SVP reports 787 shares withheld for taxes - Stock Titan
Amgen (AMGN) EVP Jonathan Graham reports tax-withholding of 5,353 shares - Stock Titan
Amgen (AMGN) CEO Bradway reports 21,294-share tax-withholding transaction - Stock Titan
Amgen (AMGN) finance VP reports 327-share tax withholding, holds 4,048 shares - Stock Titan
Bank of America Securities Maintains a Sell Rating on Amgen (AMGN) - MSN
Amgen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
1.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):